|
Bayer to acquire Steigerwald Arzneimittelwerk GmbH |
|
Bayer to acquire Steigerwald Arzneimittelwerk GmbH |
|
NAFDAC to Prosecute Owners of Fake Drugs' Warehouses |
|
NAFDAC to Prosecute Owners of Fake Drugs' Warehouses |
|
Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - Top 3 U.S. ~$3.0 Billion Revenue Specialty Brand Business -- Expands Portfolio and Pipeline in Core Areas of Women's Health and |
|
Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - Top 3 U.S. ~$3.0 Billion Revenue Specialty Brand Business -- Expands Portfolio and Pipeline in Core Areas of Women's Health and |
|
MWV Healthcare, Optum and Venebio Group selected to present at the ISPOR 18th Annual International Meeting |
|
MWV Healthcare, Optum and Venebio Group selected to present at the ISPOR 18th Annual International Meeting |
|
STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial |
|
STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial |
|
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients with Schizophrenia Compared to Seroquel XR® (quetiapine XR) |
|
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients with Schizophrenia Compared to Seroquel XR® (quetiapine XR) |
|
Global Vision Text Comparison Software Docu-Proof Recognized by the EMA for Regulatory Submissions With Docu-Proof, annual update and change notification fees reduced by 50% |
|
Global Vision Text Comparison Software Docu-Proof Recognized by the EMA for Regulatory Submissions With Docu-Proof, annual update and change notification fees reduced by 50% |
|
Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin |
|
Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin™ |
|
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent |
|
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent |
|
Best of the Healthcare Supply Chain Honored with GHXcellence Awards |
|
Best of the Healthcare Supply Chain Honored with GHXcellence Awards |
|
Medtronic cutting 500 jobs in Minnesota, 2,000 total |
|
Medtronic cutting 500 jobs in Minnesota, 2,000 total |
|
UCB and IBM Collaborate to Personalize Care for Epilepsy Patients - Project Will Use Big Data and Analytics to Address Pressing Public Health Issue |
|
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. |
|
NAFDAC to Prosecute Owners of Fake Drugs' Warehouses |
